Hong Kong Stock Movement | CLOUDR (09955) Surges Over 4% in Morning Session as Company's Generative Medical AI Large Model Research Project Selected for Hangzhou Key Scientific Research Plan

Stock News
08/01

CLOUDR (09955) surged over 4% in morning trading. As of press time, the stock was up 4.03% to HK$1.55, with a turnover of HK$3.1421 million.

On the news front, Hangzhou Science and Technology Bureau recently officially announced the list of approved projects for the "2025 Municipal Key Scientific Research Plan." CLOUDR's (Hangzhou Kangsheng Health Management Consulting Co., Ltd.) project titled "Construction of Generative Medical AI Large Model and Key Technology Research for Remote Decision Support" successfully made the list, once again demonstrating the company's strong capabilities in the medical AI field.

Currently, the medical AI large model has been piloted in multiple hospitals nationwide, with plans to further expand coverage and application depth to benefit more medical institutions and patients.

According to reports, CLOUDR's generative medical AI large model is based on a medical information transmission system utilizing IoT sensing technology and precise data routing algorithms. Through multimodal sensing devices, it conducts dynamic data collection of health parameters for chronic disease patients in typical clinical scenarios, establishing encrypted transmission channels and data cleaning mechanisms for telemedicine.

The company has also developed an intelligent diagnostic assistance system with parameter self-optimization capabilities. Through deep reinforcement learning, it achieves real-time dynamic tuning of decision model parameters, focusing on improving the accuracy and timeliness of remote diagnosis for clinical scenarios including diabetes, cardiovascular diseases, and chronic obstructive pulmonary disease. This creates a comprehensive closed-loop medical assistance system covering "data collection - secure transmission - intelligent decision-making."

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10